Journal
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 71, Issue 16, Pages 1797-1813Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2018.02.033
Keywords
hypertension; pregnancy-related hypertension; prevention; race and ethnicity; women
Categories
Funding
- National Heart, Lung, and Blood Institute (NHLBI) [N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164, RO1-HL-073412-01, U0164829, U01 HL649141, U01 HL649241]
- Gustavus and Louis Pfeiffer Research Foundation
- Women's Guild of Cedars-Sinai Medical Center
- Ladies Hospital Aid Society of Western Pennsylvania
- QMED, Inc. (Laurence Harbor, New Jersey)
- Edythe L. Broad Endowment
- Barbra Streisand Women's Cardiovascular Research and Education Program
- Linda Joy Pollin Women's Heart Health Program
- Cedars-Sinai Medical Center
- Emory Women's Heart Center, Emory University School of Medicine
- Alnylam Pharmaceuticals
- Gilead Sciences
- NHLBI
- Pfizer
- Society for Women's Health Research
- National Institutes of Health Pharmacogenomics Research Network [U01-GM074492]
- Boehringer Ingelheim
- Gatorade Trust through University of Florida, Department of Medicine
- Gatorade Trust through National Institutes of Health, National Center for Advancing Translational Sciences-University of Florida Clinical and Translational Science [UL1TR001427]
- Gatorade Trust through PCORnet-OneFlorida Clinical Research Consortium [CDRN-1501-26692]
- Gatorade Trust through U.S. Department of Defense [CDMRP PR161603]
- Adelphi Values
- Amgen
- AstraZeneca
- Athersys
- Brigham and Women's Hospital
- Capricor Inc.
- Cytori Therapeutics
- Daiichi-Sankyo
- Department of Defense
- Duke University
- Gilead Sciences, Inc.
- inVentive Health Clinical LLC
- Merck Co.
- National Institutes of Health/NHLBI
- Minocycline HTN
- Microbiota HTN
- Microbiota
- Relypsa
- Sanofi
Ask authors/readers for more resources
Hypertension accounts for 1 in 5 deaths among American women, posing a greater burden for women than men, and is among their most important risk factors for death and development of cardiovascular and other diseases. Hypertension affects women in all phases of life, with specific characteristics relating to risk factors and management for primary prevention of hypertension in teenage and young adult women; hypertension in pregnancy; hypertension during use of oral contraceptives and assisted reproductive technologies, lactation, menopause, or hormone replacement; hypertension in elderly women; and issues of race and ethnicity. All are detailed in this review, as is information relative to women in clinical trials of hypertension and medication issues. The overarching message is that effective treatment and control of hypertension improves cardiovascular outcomes. But many knowledge gaps persist, including the contribution of hypertensive disorders of pregnancy to cardiovascular disease risk, the role of hormone replacement, blood pressure targets for elderly women, and so on. (c) 2018 the American College of Cardiology Foundation. Published by Elsevier. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available